345
Views
25
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of polylactic acid nanoparticles safety using Drosophila model

, , , , &
Pages 1136-1143 | Received 16 Oct 2015, Accepted 10 Apr 2016, Published online: 16 May 2016
 

Abstract

Cytotoxicity of nanoparticles and their sub-lethal effect on cell behavior and cell fate are a high topic of studies in the nanomaterial field. With an explosion of nanoparticle types (size, shape, polarity, stiffness, composition, etc.), Drosophila has become an attractive animal model for high throughput analysis of these nanocarriers in the drug delivery field with applications in cancer therapy, or simply to generate a fast and complete cytotoxic study of a peculiar nanoparticle. In respect to that, we have conducted an in cellulo study of poly(lactic acid) (PLA) nanoparticle cytotoxicity, and determined that near lethal nanoparticle doses, oxidative stress as well as P53 and ATP pathways may lead to cell cycle arrest at G1, and ultimately to cell death. Neither viability nor the development of Drosophila larvae are affected by the ingestion of PLA nanoparticles at sub-lethal concentrations. Drosophila will be a useful model to study PLA and PLA-modified nanoparticle toxicity, and nanoparticle fate after ingestion.

View correction statement:
Corrigendum

Acknowledgements

We are indebted to Cyrille Alexandre for critically reading the manuscript.

Declaration of interest

The authors report no conflict of interest. This work has been supported in part by the European Commission FP7 ADITEC program (HEALTH-F4-2011-280873) and FP7 CutHIVac (HEALTH- 241904) to S.L., J.Y.E. and B.V., the Fondation Pierre Bergé - Yves Saint-Laurent (B.V.), and the ANR (grant ANR PECSDDeli and Euronanomed iNanoDCs; support to B.V.).

Supplementary material available online

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.